FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
Wedbush analyst David Nierengarten lowered the price target on AnaptysBio (NASDAQ: ANAB) to $146.00 (from $147.00) while maintaining a Outperform rating.
... More
